These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 21803751

  • 1. Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression.
    Aletaha D, Alasti F, Smolen JS.
    Ann Rheum Dis; 2011 Nov; 70(11):1975-80. PubMed ID: 21803751
    [Abstract] [Full Text] [Related]

  • 2. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D, Smolen JS.
    Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
    [Abstract] [Full Text] [Related]

  • 3. Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.
    Weinblatt ME, Keystone EC, Cohen MD, Freundlich B, Li J, Chon Y, Baumgartner SW.
    J Rheumatol; 2011 Feb; 38(2):242-6. PubMed ID: 21078715
    [Abstract] [Full Text] [Related]

  • 4. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF, Westhovens R, Reed DM, Fanti L, Becker JC, Covucci A, Keystone EC.
    J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Brahe CH, Østergaard M, Johansen JS, Defranoux N, Wang X, Bolce R, Sasso EH, Ørnbjerg LM, Hørslev-Petersen K, Stengaard-Pedersen K, Junker P, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Lottenburger T, Ammitzbøll C, Jørgensen A, Krintel SB, Raun J, Hetland ML.
    Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission.
    Kuriya B, Arkema EV, Bykerk VP, Keystone EC.
    Ann Rheum Dis; 2010 Jul; 69(7):1298-304. PubMed ID: 20421343
    [Abstract] [Full Text] [Related]

  • 7. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM, Østergaard M, Bøyesen P, Krogh NS, Thormann A, Tarp U, Poulsen UE, Espesen J, Schlemmer A, Graudal N, Kollerup G, Jensen DV, Madsen OR, Glintborg B, Christensen T, Lindegaard H, Bøhme W, Hansen A, Andersen AR, Hetland ML.
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [Abstract] [Full Text] [Related]

  • 8. Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients.
    Aletaha D, Alasti F, Smolen JS.
    Ann Rheum Dis; 2013 Jan; 72(1):7-12. PubMed ID: 22915619
    [Abstract] [Full Text] [Related]

  • 9. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN, Bergman MJ, Yourish J, Pei J, Reiss W, Keystone E.
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [Abstract] [Full Text] [Related]

  • 10. Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes.
    Bathon J, Robles M, Ximenes AC, Nayiager S, Wollenhaupt J, Durez P, Gomez-Reino J, Grassi W, Haraoui B, Shergy W, Park SH, Genant H, Peterfy C, Becker JC, Covucci A, Moniz Reed D, Helfrick R, Westhovens R.
    Ann Rheum Dis; 2011 Nov; 70(11):1949-56. PubMed ID: 21821865
    [Abstract] [Full Text] [Related]

  • 11. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
    van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S.
    Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208
    [Abstract] [Full Text] [Related]

  • 12. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, Breedveld FC, Furst DE, Lipsky PE, ATTRACT Study Group.
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [Abstract] [Full Text] [Related]

  • 13. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y, Youssef SS, El Gaafary M.
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [Abstract] [Full Text] [Related]

  • 14. Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study.
    Keystone EC, Haraoui B, Guérette B, Mozaffarian N, Liu S, Kavanaugh A.
    J Rheumatol; 2014 Feb; 41(2):235-43. PubMed ID: 24293583
    [Abstract] [Full Text] [Related]

  • 15. Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.
    Pincus T, Richardson B, Strand V, Bergman MJ.
    Clin Exp Rheumatol; 2014 Feb; 32(5 Suppl 85):S-47-54. PubMed ID: 25365089
    [Abstract] [Full Text] [Related]

  • 16. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
    Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, Ernestam S, Geborek P, Pettersson IF, van Vollenhoven RF.
    Ann Rheum Dis; 2012 Feb; 71(2):186-91. PubMed ID: 21930734
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K, Okubo T, Sato T, Ito H, Fukai R, Baba H.
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [Abstract] [Full Text] [Related]

  • 18. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
    Ellingsen T, Hansen I, Thorsen J, Møller BK, Tarp U, Lottenburger T, Andersen LS, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen A, Lindegaard H, Jacobsen S, Østergaard M, Vestergaard A, Jurik AG, Junker P, Christensen AF, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K.
    Scand J Rheumatol; 2014 Jan; 43(2):91-100. PubMed ID: 23980529
    [Abstract] [Full Text] [Related]

  • 19. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.
    Vastesaeger N, Xu S, Aletaha D, St Clair EW, Smolen JS.
    Rheumatology (Oxford); 2009 Sep; 48(9):1114-21. PubMed ID: 19589891
    [Abstract] [Full Text] [Related]

  • 20. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
    Landewé R, van der Heijde D, Klareskog L, van Vollenhoven R, Fatenejad S.
    Arthritis Rheum; 2006 Oct; 54(10):3119-25. PubMed ID: 17009230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.